Почетна › Рак (све врсте) › Вирџинија
Kliničke studije za Рак (све врсте) u državi Вирџинија
77 studija za Рак (све врсте) traži učesnike na lokacijama u državi Вирџинија.
Gradovi u državi Вирџинија
Zvanični tekst studije (na engleskom)
A Study to Evaluate the Safety and Efficacy of MK-3120 in Participants With Advanced Solid Tumors (MK-3120-002)
- Virginia Commonwealth University ( Site 1008), Richmond
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 13. 11. 2026. · NCT06818643A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma
- Virginia Cancer Specialists - Fairfax /ID# 268559, Fairfax
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 10. 11. 2026. · NCT05650632RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
- UVA Center for Psychiatric Clinical Research, Charlottesville
Тражи се учесникФаза 2
Узраст од 18 до 80 · Оба пола · Ажурирано 10. 11. 2026. · NCT07002034Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
- University of Virginia Cancer Center, Charlottesville
- VCU Massey Comprehensive Cancer Center, Richmond
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 9. 11. 2026. · NCT06580314Beginning Radiation Immediately With GammaTile at GBM Excision Versus Standard of Care
- Inova Schar Cancer Institute, Fairfax
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 9. 11. 2026. · NCT07195591A Study of ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors
- NEXT Virginia, Fairfax
Тражи се учесникФаза 1
Узраст од 18 до 99 · Оба пола · Ажурирано 6. 11. 2026. · NCT06983743Safety and Efficacy of Epcoritamab With Gemcitabine, Dexamethasone, and Cisplatin (GDP) Salvage Chemotherapy in Relapsed Refractory Large B-cell Lymphoma
- University of Virginia Health System, Charlottesville
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 5. 11. 2026. · NCT05852717A Study to Investigate the Safety, Pharmacokinetics, and Preliminary Efficacy of IDE574 Therapy in Adult Participants With Advanced Solid Tumors
- NEXT Virginia, Fairfax
Тражи се учесникФаза 1
Узраст од 18 до 99 · Оба пола · Ажурирано 5. 11. 2026. · NCT07540572A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
- Inova Schar Cancer Institute Clinical Trials, Fairfax
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 5. 11. 2026. · NCT06901531Distance-Based Exercise to Preserve Function and Prevent Disability
- Bon Secours Memorial Regional Medical Center, Mechanicsville
- Bon Secours Saint Francis Medical Center, Midlothian
- Bon Secours Saint Mary's Hospital, Richmond
Тражи се учесник
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT07059884A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
- University of Virginia Health System, Charlottesville
- USO - Virginia Cancer Specialists, Fairfax
- VCU Health Adult Outpatient Pavillion, Richmond
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT06119581Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors
- Virginia Cancer Specialists, Fairfax
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 3. 11. 2026. · NCT05856981Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
- University Of Virginia Health System, Charlottesville
Тражи се учесникФаза 2/3
Сви узрасти · Оба пола · Ажурирано 2. 11. 2026. · NCT03435796A Study to Evaluate the Efficacy and Safety of Sutetinib Maleate Capsule in Locally Advanced or Metastatic NSCLC
- Virginia Cancer Specialists, Fairfax
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 2. 11. 2026. · NCT06010329A Study of ARC-02 in B-cell NHL
- Massey Cancer Center, Richmond
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 2. 11. 2026. · NCT07691606A Clinical Study of Calderasib (MK-1084) in People With Advanced Solid Tumors (MK-1084-014)
- Virginia Cancer Specialists ( Site 1102), Fairfax
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 2. 11. 2026. · NCT07209111Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of TGW101 in Participants With Advanced Solid Tumors
- NEXT Virginia, Fairfax
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 2. 11. 2026. · NCT06959706A Clinical Study of MK-4716 in People With Certain Solid Tumors (MK-4716-001)
- NEXT Virginia ( Site 0054), Fairfax
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 30. 10. 2026. · NCT07247110PAS-004 in Patients With Advanced Solid Tumors
- NEXT Oncology, Fairfax
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 30. 10. 2026. · NCT06299839Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia
- University of Virginia Health, Charlottesville
Тражи се учесникФаза 3
Узраст од 18 до 71 · Оба пола · Ажурирано 30. 10. 2026. · NCT07504458A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors
- NEXT Oncology Virginia, Fairfax
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 29. 10. 2026. · NCT07094204Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradiotherapy (cCRT) in People With Muscle Invasive Bladder Cancer (EV-309)
- University of Virginia Comprehensive Cancer Center, Charlottesville
- Virginia Oncology Associates, Norfolk
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 28. 10. 2026. · NCT07566156Study to Evaluate Sutetinib Maleate Capsule in Locally Advanced or Metastatic Non-small Cell Lung Cancer
- Virginia Cancer Specialists, Fairfax
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 27. 10. 2026. · NCT05168566Safety, Pharmacokinetics, and Preliminary Efficacy of VIR-5500 (AMX-500) in Prostate Cancer
- NEXT Virginia, Fairfax
Тражи се учесникФаза 1
Узраст 18 и старији · Мушкарци · Ажурирано 27. 10. 2026. · NCT05997615Heuristic Tool To Improve Symptom Self-Management in Adolescents and Young Adults With Cancer
- Virginia Commonwealth University, Richmond
Тражи се учесник
Узраст од 15 до 29 · Оба пола · Ажурирано 26. 10. 2026. · NCT05958316A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
- Research Site, Fairfax
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 26. 10. 2026. · NCT06835569Phase 1/2 Study of BHB810 in Advanced Gastric and GEJ Adenocarcinoma
- NEXT Virginia, Fairfax
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 20. 10. 2026. · NCT07529808A Phase IIIb Study to Evaluate Camizestrant Plus Ribociclib in ER-positive, HER2-negative Advanced Breast Cancer
- Research Site, Midlothian
Тражи се учесникФаза 3
Узраст од 18 до 130 · Оба пола · Ажурирано 19. 10. 2026. · NCT07647328Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
- NEXT Oncology Virginia, Fairfax
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 19. 10. 2026. · NCT06162221A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
- VCU Medical Center Gateway Building, Richmond
- Virginia Commonwealth University, Richmond
- VCU Health Short Pump Pavilion, Richmond
- и још 4
Тражи се учесникФаза 2/3
Узраст 18 и старији · Оба пола · Ажурирано 14. 10. 2026. · NCT06989437A Study of ASP3082 in Adults With Advanced Solid Tumors
- NEXT Oncology - Virginia Cancer Specialists, Fairfax
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 14. 10. 2026. · NCT05382559Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
- NEXT, Fairfax
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 13. 10. 2026. · NCT06993844Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer
- Virginia Cancer Institute, Norfolk
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 9. 10. 2026. · NCT05386108A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease
- Inova Schar Cancer Institute - Fairfax - Innovation Park Drive /ID# 274586, Fairfax
- Virginia Cancer Specialists - Fairfax /ID# 274339, Fairfax
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 9. 10. 2026. · NCT07023289FOG-001 in Locally Advanced or Metastatic Solid Tumors
- University of Virginia, Charlottesville
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 7. 10. 2026. · NCT05919264A Study to Assess Adverse Events, Change in Disease Activity of Intravenous Telisotuzumab Adizutecan in Combination With Osimertinib as First-Line Treatment in Adult Participants With Locally Advanced Unresectable or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
- Virginia Cancer Specialists - Fairfax /ID# 275071, Fairfax
Тражи се учесникФаза 2/3
Узраст 18 и старији · Оба пола · Ажурирано 5. 10. 2026. · NCT07005102A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies
- Next Virginia /ID# 279684, Fairfax
Тражи се учесникФаза 2
Узраст 18 и старији · Жене · Ажурирано 1. 10. 2026. · NCT07024784A Study of PHN-012 in Patients With Advanced Solid Tumors
- PHN-012-001 Site, Fairfax
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 29. 9. 2026. · NCT07127874REC-7735 in Participants With Solid Tumors
- NEXT Virginia, Fairfax
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 29. 9. 2026. · NCT07819136Registry Study for Radiation Therapy Outcomes
- Inova Schar Cancer Institute, Fairfax
- Hampton University Proton Therapy Institute, Hampton
Тражи се учесникОпсервациона студија
Сви узрасти · Оба пола · Ажурирано 29. 9. 2026. · NCT01255748Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.